Form4insider filings, from the source

SEC Form 4 · accession 0001578563-15-000012

Nuo Therapeutics, Inc. · AURX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
B. Jefferson Clark
10% Owner · Other
Aldagen Holdings, LLC
10% Owner · Other
William W Brooke
10% Owner · Other
Period of report
Jun 13, 2013
Accepted (ET)
Mar 12, 2015 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 13, 2013J105,300$0.00D11,936,265D
Common StockF3,F2Nov 11, 2014J1,270,000$1.18A13,206,265D
Common StockF2Dec 30, 2014S1,200$0.35D13,205,065D
Common StockF2Jan 9, 2015S15,850$0.35D13,189,215D
Common StockF4holding———108,830ISee Footnote 4
Common StockF5holding———157,276ISee Footnote 5
Common StockF6holding———175,533ISee Footnote 6
Common StockF7holding———429,404ISee Footnote 7
Common StockF8holding———60,494ISee Footnote 8

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to buy)F4$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock15,61615,616I
Warrant (right to buy)F5$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock22,56722,567I
Warrant (right to buy)F6$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock63,63663,636I
Warrant (right to buy)F7$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock63,63663,636I
Warrant (right to buy)F8$0.75holding———Feb 22, 2013Feb 21, 2018Common Stock12,72712,727I

Explanation of responses